Description

2-[2-(4-Methoxybenzyl)-8,9-Dimethyl-7H-Pyrrolo[3,2-E][1,2,4]Triazolo[1,5-C]Pyrimidin-7-Yl]Ethanol is a high-purity, complex heterocyclic compound that serves as a critical advanced intermediate in modern pharmaceutical synthesis. Its intricate fused-ring structure makes it a valuable building block for developing novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. This compound is primarily required by research institutions and pharmaceutical manufacturers engaged in the development of new drugs, particularly in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, especially those targeting central nervous system (CNS) disorders or oncological pathways.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization processes in academic and industrial labs.
• Active Pharmaceutical Ingredient (API) Synthesis: Incorporated into the final synthetic steps for producing proprietary pharmaceutical compounds.
• Biochemical Research: Potential use as a tool compound or probe in biochemical assays to study specific enzyme interactions or receptor binding.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP conditions.

Basic Information

Product Name	2-[2-(4-Methoxybenzyl)-8,9-Dimethyl-7H-Pyrrolo[3,2-E][1,2,4]Triazolo[1,5-C]Pyrimidin-7-Yl]Ethanol
CAS No.	921061-24-7
Molecular Formula	C21H23N5O2
Molecular Weight	377.44 g/mol
Synonyms	7H-Pyrrolo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-7-ethanol, 2-[2-[(4-methoxyphenyl)methyl]-8,9-dimethyl-; 2-(2-(4-Methoxybenzyl)-8,9-dimethyl-7H-pyrrolo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)ethan-1-ol; 921061-24-7; UNII-9J8F8YV8JI; 9J8F8YV8JI; Ethan-1-ol derivative of pyrrolotriazolopyrimidine
EINECS	Contact for details

Quality Control

Our 2-[2-(4-Methoxybenzyl)-8,9-Dimethyl-7H-Pyrrolo[3,2-E][1,2,4]Triazolo[1,5-C]Pyrimidin-7-Yl]Ethanol is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D and synthesis. Certificates of Analysis (COA) with complete traceability are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept in a well-ventilated area. Due to its light-sensitive nature, prolonged exposure to direct light should be avoided.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.